Overview
Matthew Wilson practices in Leuven, Belgium. Mr. Wilson is rated as an Advanced expert by MediFind in the treatment of DPAGT1-CDG. His top areas of expertise are DPAGT1-CDG, SRD5A3-CDG, Pyridoxine Deficiency, and Molybdenum Cofactor Deficiency (MoCD).
His clinical research consists of co-authoring 19 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of DPAGT1-CDG.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- DPAGT1-CDGMr. Wilson isAdvanced. Learn about DPAGT1-CDG.
- SRD5A3-CDGMr. Wilson isAdvanced. Learn about SRD5A3-CDG.
- Experienced
- EpilepsyMr. Wilson isExperienced. Learn about Epilepsy.
- Hypophosphatasia (HPP)Mr. Wilson isExperienced. Learn about Hypophosphatasia (HPP).
- Membranoproliferative Glomerulonephritis
- Molybdenum Cofactor Deficiency (MoCD)Mr. Wilson isExperienced. Learn about Molybdenum Cofactor Deficiency (MoCD).
- Pyridoxine DeficiencyMr. Wilson isExperienced. Learn about Pyridoxine Deficiency.
- X-Linked Severe Combined Immunodeficiency